@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAgFR7oBTN82oP-Kzfkz2CArarqqCSbcCiAf4nXkgrUxw> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAgFR7oBTN82oP-Kzfkz2CArarqqCSbcCiAf4nXkgrUxw#> .
@prefix beldoc: <http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix go: <http://amigo.geneontology.org/amigo/term/GO:> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix mgi: <http://www.informatics.jax.org/marker/MGI:> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix hasAgent: <http://semanticscience.org/resource/SIO_000139> .
@prefix schem: <http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-chemical-names/> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix mesh: <http://purl.bioontology.org/ontology/MSH/> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
  sub:_1 hasAgent: sub:_2 ;
    a go:0042789 .
  sub:_2 geneProductOf: mgi:97747 ;
    a Protein: .
  sub:_3 rdf:object schem:serum%20fatty%20acid ;
    rdf:predicate belv:decreases ;
    rdf:subject schem:serum%20insulin ;
    a rdf:Statement .
  sub:_4 occursIn: mesh:D018482 , species:10090 ;
    rdf:object sub:_3 ;
    rdf:predicate belv:increases ;
    rdf:subject sub:_1 ;
    a rdf:Statement .
  sub:assertion rdfs:label "a(SCHEM:\"serum insulin\") -| a(SCHEM:\"serum fatty acid\")" , "tscript(p(MGI:Pparg)) -> (a(SCHEM:\"serum insulin\") -| a(SCHEM:\"serum fatty acid\"))" .
}
sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_6 ;
    pav:version "1.4" .
  sub:_5 prov:value "Secondary insulin resistance in liver and adipose tissue Steady-state circulating free fatty acid (FFA) levels represent a balance between FFA production and removal. The acute effects of insulin in lowering FFA levels are due, in large part, to insulin's antilipolytic effects in adipose tissue. In control animals, insulin infusion suppressed FFA levels by approx60% in both 6- and 14-month-old mice (Fig. 4a). This effect was significantly blunted in 6- and 14-month-old MKOfl/fl (P = 0.0089 and P = 0.01, respectively) mice, as well as 14-month-old MKOfl/- mice (P = 0.009), as fatty acid levels in those mice were depressed by only approx30%." ;
    prov:wasQuotedFrom pubmed:14625542 .
  sub:_6 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:14625542 ;
    prov:wasDerivedFrom beldoc: , sub:_5 .
}
sub:pubinfo {
  this: dct:created "2014-07-03T14:30:18.438+02:00"^^xsd:dateTime ;
    pav:createdBy orcid:0000-0001-6818-334X , orcid:0000-0002-1267-0234 .
}